Crescendo Biologics (Formerly Translocus)
Biopharmaceutical developing potent, highly differentiated Humabody® VH therapeutics in Oncology.. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€285m (Public information from Jul 2023)
Company register number 06425006
Cambridge England (HQ)
Authorizing premium user...